Literature DB >> 11187972

Differential effect of frusemide on renal medullary and cortical blood flow in the anaesthetised rat.

L Dobrowolski1, B B dzyńska, J Sadowski.   

Abstract

In addition to its known effect on renal tubular transport, frusemide (furosemide) has been shown to affect renal circulation. This study in the anaesthetised rat examined the influence of frusemide (bolus 0.25 or 0.5 mg kg(-1) I.V., then infusion delivering the same dose over 1 h) on renal cortical and medullary circulation measured as laser-Doppler blood (cell) flux. The responses were compared with simultaneously measured changes in renal excretion and in the tissue admittance, an index of medullary ionic hypertonicity of the interstitium. Renal vascular responses to frusemide were significant but not dose dependent. During low-dose frusemide infusion cortical flux decreased 11.5 +/- 0.9% and medullary flux decreased 32.3 +/- 3.5% (difference significant at P < 0.001). During high-dose infusion the decreases were by 13.5 +/- 1.4 and 29.3 +/- 3.8%, respectively (difference significant at P < 0.001). Sodium excretion increased 15-fold (by 3.7 +/- 0.4 micromol x min(-1)) and 30-fold (by 5.9 +/- 1.1 micromol x min(-1)) during low- and high-rate infusion of frusemide, respectively. By contrast, medullary tissue admittance decreased similarly with the two doses: maximally by 13.4 +/- 1.4 and 10.9 +/- 0.9%, respectively. The observations that an exaggerated post-frusemide decrease in blood flow within the medulla coincided with decreasing tissue admittance in this zone and that neither medullary blood flow nor admittance changes were related to the dose suggest a causal relationship between interstitial ionic hypertonicity and vascular resistance. We propose that the post-frusemide decrease in medullary tissue NaCl depressed medullary circulation by inhibiting local generation of vasodilator prostaglandins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11187972

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  7 in total

1.  Furosemide-induced renal medullary hypoperfusion in the rat: role of tissue tonicity, prostaglandins and angiotensin II.

Authors:  Leszek Dobrowolski; Janusz Sadowski
Journal:  J Physiol       Date:  2005-06-16       Impact factor: 5.182

2.  A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate.

Authors:  Qing Zhu; Min Xia; Zhengchao Wang; Pin-Lan Li; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-06

3.  Antimicrobial therapy with aminoglycoside or meropenem in the intensive care unit for hospital associated infections and risk factors for acute kidney injury.

Authors:  Raphael Donadio Pitta; Juliano Gasparetto; Thyago Proença De Moraes; João Paulo Telles; Felipe Francisco Tuon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-12       Impact factor: 3.267

4.  Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys.

Authors:  Min Xia; Li Chen; Rachel W Muh; Pin-Lan Li; Ningjun Li
Journal:  J Pharmacol Exp Ther       Date:  2009-02-26       Impact factor: 4.030

5.  Predicting restoration of kidney function during CRRT-free intervals.

Authors:  Daniel Heise; Daniel Gries; Onnen Moerer; Annalen Bleckmann; Michael Quintel
Journal:  J Cardiothorac Surg       Date:  2012-01-18       Impact factor: 1.637

6.  Furosemide is associated with acute kidney injury in critically ill patients.

Authors:  T M Levi; M S Rocha; D N Almeida; R T C Martins; M G C Silva; N C P Santana; I T Sanjuan; C M S Cruz
Journal:  Braz J Med Biol Res       Date:  2012-05-31       Impact factor: 2.590

7.  Loop Diuretics Are Associated with Increased Risk of Hospital-Acquired Acute Kidney Injury in Adult Patients: A Retrospective Study.

Authors:  Liping Zhou; Yanqin Li; Qi Gao; Yuxin Lin; Licong Su; Ruixuan Chen; Yue Cao; Ruqi Xu; Fan Luo; Peiyan Gao; Xiaodong Zhang; Pingping Li; Sheng Nie; Ying Tang; Xin Xu
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.